The Exciting Potential of Electric Field Stimulation – Cellectricon presents data at Neuroscience 2013

Improved drug delivery and compound identification with the Cellaxess technology

Molndal, Sweden – 30 October 2013 – Cellectricon, a leading provider of advanced cell-based screening technologies and services, will be presenting new data at Neuroscience 2013, 9-13 November, San Diego (USA). In a series of poster presentations, Cellectricon (booth #933) will demonstrate how its technology can be applied effectively for drug discovery, particularly in relation to cytoskeletal disorders and neurodegenerative diseases. Cellectricon’s novel approach is based around electric field stimulation, and the posters, which include primary data, detail how the Cellaxess technology can be used to deliver pharmacologically active molecules to neuronal cultures without compromising cell viability or functionality. The poster session will also reveal an assay for the high-throughput identification of compounds that modulate neuronal excitability. In this way, attendees will be shown how compound characterization and data-based decision making can be achieved early in a project life-cycle, reducing unnecessary time and cost.

The poster presentations take place on 11-13 November, and Cellectricon employees will be on-hand to answer any questions you may have during this time. Please visit the Cellectricon website for more information on the content of the posters, or follow the links below. Cellectricon will also be exhibiting at booth #933, so drop by to learn more about Cellectricon’s Discovery Services, launched earlier this year.

Small Molecule Delivery into primary neuronal cells capillary-electrode Electroporation Monday 11 Nov, 10-11am

A method for patch-clamp recordings of fast-acting ion channels in rat dorsal root ganglion cells Tuesday 12 Nov, 11-12am

Characterization of the subpopulation of neurons responding in an electric field stimulation assay Wednesday 13 Nov, 2-3pm

Development of a high throughput electric field stimulation assay for identification of compounds modulating excitability in sensory neurons Wednesday 13 Nov, 4-5pm

For more information on Cellectricon, visit www.cellectricon.com

About Cellectricon
Cellectricon provides state-of-the-art discovery services and enabling technologies to accelerate drug discovery and cell-based research. Our compound profiling services in excitable cells and native tissue provide researchers with decision-making insight into the science of cytoskeletal disturbances, with an initial focus on chronic pain.